FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Real-time Bid/Ask 04:50:51 05/06/2024 pm IST | ||
| 9.87 EUR / 10 EUR | -0.45% |
|
| Current month | -9.36% | ||
| 1 month | -5.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 9.85 | -1.30% |
| 04/24/04 | 9.98 | -1.77% |
| 03/24/03 | 10.16 | -7.72% |
| 31/24/31 | 11.01 | -0.45% |
| 30/24/30 | 11.06 | +1.47% |
Delayed Quote Börse Stuttgart
Last update June 05, 2024 at 02:06 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MG1SPR |
| ISIN | DE000MG1SPR9 |
| Date issued | 05/04/2024 |
| Strike | 171.6 $ |
| Maturity | Unlimited |
| Parity | 3.93 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.48 € |
|---|---|
| Lowest since issue | 9.31 € |
| Spread | 0.13 € |
| Spread % | 1.30% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7
USD
Average target price
142.7
USD
Spread / Average Target
+10.86%
- Stock Market
- Certificates
- Certificat
